OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
55
Results
Show all
Save search
Copy query
Show results for
Unknown
(55)
Publication Date
Release Date
2025
(9)
2024
(8)
2021
(6)
2020
(6)
2022
(5)
2018
(5)
2023
(4)
2019
(4)
2015
(3)
2016
(2)
2026
(1)
2017
(1)
2003
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Comparison of Unplanned Intensive Care Unit Readmission Scores: A Prospective Cohort Study.
Not available
S-EPMC4658118
|
biostudies-literature
Cite
Multicenter cross-sectional study of HTLV-1 prevalence and associated risk factors in epidemiologically relevant groups across Brazil.
Not available
S-EPMC11911192
|
biostudies-literature
Cite
Extracellular Vesicles isolated from Mesenchymal Stromal Cells Modulate CD4+ T Lymphocytes Toward a Regulatory Profile.
Not available
S-EPMC7226573
|
biostudies-literature
Cite
Chikungunya virus Detection in Aedes aegypti and Culex quinquefasciatus during an Outbreak in the Amazon Region.
Not available
S-EPMC7472183
|
biostudies-literature
Cite
Increasing COVID-19 Testing and Vaccination Uptake in the Take Care Texas Community-Based Randomized Trial: Adaptive Geospatial Analysis.
Not available
S-EPMC11835599
|
biostudies-literature
Cite
Developing Cardio-Oncology Programs in the New Era: Beyond Ventricular Dysfunction Due to Cancer Treatments.
Not available
S-EPMC10742309
|
biostudies-literature
Cite
The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia.
Not available
S-EPMC6503680
|
biostudies-literature
Cite
Ketamine, Etomidate, and Mortality in Emergency Department Intubations.
Not available
S-EPMC12706683
|
biostudies-literature
Cite
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.
Not available
S-EPMC6624831
|
biostudies-literature
Cite
Seven versus 14 days of antimicrobial therapy for severe multidrug-resistant Gram-negative bacterial infections in intensive care unit patients (OPTIMISE): a randomised, open-label, non-inferiority clinical trial.
Not available
S-EPMC11653996
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets